Views & Analysis Tracking studies: moving with the times Awareness, Trial, and Usage tracking can be enhanced if technology updates it in real time.
News Novo Nordisk closes on EU okay for haemophilia antibody Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.